Cargando…
Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The viral outbreak started in late 2019 and rapidly became a serious health threat to the global population. COVID-19 was declared a pandemic by the World Health Organization in March 2020....
Autores principales: | Li, Qingxin, Kang, CongBao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463875/ https://www.ncbi.nlm.nih.gov/pubmed/32824639 http://dx.doi.org/10.3390/microorganisms8081250 |
Ejemplares similares
-
Insights into Structures and Dynamics of Flavivirus Proteases from NMR Studies
por: Li, Qingxin, et al.
Publicado: (2020) -
Structure and Dynamics of Zika Virus Protease and Its Insights into Inhibitor Design
por: Li, Qingxin, et al.
Publicado: (2021) -
Secondary Structures of the Transmembrane Domain of SARS-CoV-2 Spike Protein in Detergent Micelles
por: Li, Qingxin, et al.
Publicado: (2022) -
Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors
por: Kumar, Vathan, et al.
Publicado: (2016) -
Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)